Troglitazone suppresses intimal formation following balloon injury in insulin-resistant Zucker fatty rats

Atherosclerosis

Volumn 136, Issue 2, 1998, Pages 275-279

  Shinohara, Etsuko ^a   Kihara, Shinji ^a   Ouchi, Noriyuki ^a   Funahashi, Tohru ^a   Nakamura, Tadashi ^a   Yamashita, Shizuya ^a   Kameda Takemura, Kaoru ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Insulin resistance; Troglitazone; Vascular smooth muscle cell

Indexed keywords

INSULIN RECEPTOR; TROGLITAZONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; BALLOON DILATATION; CELL DIVISION; CELLS, CULTURED; CHROMANS; DNA; ENDOTHELIUM, VASCULAR; INSULIN RESISTANCE; MALE; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, ZUCKER; THIAZOLES; THIAZOLIDINEDIONES; TUNICA INTIMA;

EID: 0032006966     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00220-7     Document Type: Article

References (15)

1. Kellerer M., Kroder G., Tippmer S., Berti L., Kiehn R., Mosthaf L., Haring H. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes. 43:1994;447-453.
2. Maegawa H., Ide R., Hasegawa M., Ugi S., Egawa K., Iwanishi M., Kikkawa R., Shigeta Y., Kashiwagi A. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J Biol Chem. 270:1995;7724-7730.
3. King G.L., Kahn C.R., Rechler M.M., Nissley S.P. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor. J Clin Invest. 66:1980;130-140.
4. Clowes A., Reidy M., Clowes M. Mechanisms of stenosis after arterial injury. Lab Invest. 49:1993;208-215.
5. Reilly C.F., Fujita T., McFall R.C., Eng W., Johnson R.G. Pharmacological and mechanistic aspects concerning the use of Heparin and β-cyclodextrin tetradecasulfate for the treatment of vascular restenosis. Drug Dev Res. 29:1993;137-147.
6. Kadish A.H., Litle R.L., Sternberg J.C. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 14:1968;116-131.
7. Albers J.J., Tollefson J.H., Chen C.-H., Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis. 4:1984;49-58.
8. Diglio C.A., Grammas P., Giacomelli F., Wiener J. Angiogenesis in rat aorta ring explant cultures. Lab Invest. 60:1989;523-531.
9. Yamanouchi T., Shinohara T., Tagaya T., Sekino N., Ogata N., Fujimori S., Miyashita H. Pharmacokinetics study of a new oral hypoglycemic agent CS-045 in patients with non-insulin dependent diabetes mellitus. Rinshyo Iyaku (English Abstract). 11:1995;2326-2339.
10. Pfeifle B., Ditschuneit H. Two separate receptors for insulin and insulinlike growth factors on arterial smooth muscle cells. Exp Clin Endocrinol. 81:1983;280-286.
11. Pfeifle B., Ditschuneit H.H., Ditschuneit H. Binding and biological actions of insulin-like growth factors on human arterial smooth muscle cells. Horm Metab Res. 14:1982;409-414.
12. Peuler J.D., Phare S.M., Iannucci A.R., Hodorek M.J. Differential inhibitory effects of antidiabetic drugs on arterial smooth muscle cell proliferation. Am J Hypertens. 9:1996;188-192.
13. Dubey R.K., Zhang H.Y., Reddy S.R., Boegehold M.A., Kotchen T.A. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol. 265:1993;R726-732.
14. Jarrett R.J. In defence of insulin: a critique of syndrome X. Lancet. 340:1992;469-471.
15. Lippel K., Tyroler H., Eder H., Gotto A. Jr., Vahouny G. Relationship of hypertriglyceridemia to atherosclerosis. Arteriosclerosis. 1:1981;406-417.